Accueil>>Lipids>> Glycerophospholipids>>1-Arachidonoyl Lysophosphatidic Acid (ammonium salt)

1-Arachidonoyl Lysophosphatidic Acid (ammonium salt) (Synonyms: 1-Arachidonoyl LPA, 1-Arachidonoyl-sn-glycero-3-phosphate, 1-Eicosatetraenoyl-sn-glycero-3-PA, 20:4 Lyso PA, LPA(20:4), PA(20:4/0:0))

Catalog No.GC41986

1-Arachidonoyl lysophosphatidic acid is a phospholipid containing arachidonic acid at the sn-1 position.

Products are for research use only. Not for human use. We do not sell to patients.

1-Arachidonoyl Lysophosphatidic Acid (ammonium salt) Chemical Structure

Cas No.: 799268-65-8

Taille Prix Stock Qté
500μg
60,00 $US
En stock
1mg
114,00 $US
En stock
5mg
479,00 $US
En stock
10mg
720,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

1-Arachidonoyl lysophosphatidic acid is a phospholipid containing arachidonic acid at the sn-1 position. It has been found in rat brain as 37% of the arachidonic acid-containing lysophosphatidic acid (LPA) species and is a precursor to 1-arachidonoyl glycerol . 1-Arachidonoyl lysophosphatidic acid binds to the LPA2/EDG4 receptor with an EC50 value of approximately 10 nM. It prevents TNF-α and IL-6 secretion in wild-type but not Lpa2-/- dendritic cells stimulated by LPS. It also decreases differentiation of HT-29 human colon carcinoma cells to goblet cells in the presence of sodium butyrate.

Avis

Review for 1-Arachidonoyl Lysophosphatidic Acid (ammonium salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 31 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 1-Arachidonoyl Lysophosphatidic Acid (ammonium salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.